XL820
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for XL820, covering 2008-06-04 to 2008-08-18. Get the full timeline:
Most recent: Clinical Trial Update: Study of XL820 Given Orally Daily to Subjects With Solid Tumors [Phase 1]